LIPOPOLYSACCHARIDE-INDUCED SICKNESS BEHAVIOR IN PIGS IS INHIBITED BY PRETREATMENT WITH INDOMETHACIN

被引:136
作者
JOHNSON, RW [1 ]
VON BORELL, E [1 ]
机构
[1] IOWA STATE UNIV SCI & TECHNOL, DEPT ANIM SCI, AMES, IA 50011 USA
关键词
PIGS; BEHAVIOR; INDOMETHACIN; LIPOPOLYSACCHARIDE; PROSTAGLANDINS;
D O I
10.2527/1994.722309x
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Many of the behavioral responses following acute bacterial or viral infection are now considered important for maintaining homeostasis during inflammation. In the present study, we extend this concept to pigs (16 crossbred barrows) by demonstrating that lipopolysaccharide (LPS, .5, 5, or 50 mu g/kg BW) from Escherichia coli injected i.p. reduces feed intake, decreases activity, and elevates body temperature. To determine whether any of these effects could be mediated via a prostaglandin (PG)dependent mechanism, a second experiment with 16 crossbred barrows was conducted. Barrows were pretreated with indomethacin (IND, 5 mg/kg BW [a cyclooxygenase inhibitor]), and their behavior and body temperature following a challenge i.p. injection of LPS (5 mu g/kg BW) were assessed. Pretreatment with IND inhibited the anorexia and inactivity caused by LPS, suggesting that the behavioral effects of LPS are dependent on activation of a PG system. Lipopolysaccharide alone, however, did not elevate body temperature in this case; thus, the involvement of PGs in this response was not determined. Collectively, these data indicate that pigs respond to LPS by reducing feed intake, decreasing activity, and becoming febrile. The ability of IND to inhibit behavioral effects of LPS is consistent with the hypothesis that a PG system is involved in mediating sickness behavior. Perhaps, by altering the activity of cyclooxygenase it is possible to enhance or inhibit the behavioral symptoms of sickness in pigs.
引用
收藏
页码:309 / 314
页数:6
相关论文
共 37 条
[1]  
[Anonymous], 1991, PRINCIPLES PROCEDURE
[2]   BRAIN INTERLEUKIN-1 GENE-EXPRESSION INDUCED BY PERIPHERAL LIPOPOLYSACCHARIDE ADMINISTRATION [J].
BAN, E ;
HAOUR, F ;
LENSTRA, R .
CYTOKINE, 1992, 4 (01) :48-54
[3]   BIDIRECTIONAL TRANSPORT OF INTERLEUKIN-1-ALPHA ACROSS THE BLOOD-BRAIN-BARRIER [J].
BANKS, WA ;
KASTIN, AJ ;
DURHAM, DA .
BRAIN RESEARCH BULLETIN, 1989, 23 (06) :433-437
[4]   INTERLEUKIN-1 MEDIATES BEHAVIORAL BUT NOT METABOLIC EFFECTS OF TUMOR-NECROSIS-FACTOR-ALPHA IN MICE [J].
BLUTHE, RM ;
DANTZER, R ;
KELLEY, KW .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 209 (03) :281-283
[5]  
BLUTHE RM, 1991, NEUROSCI RES COMMUN, V15, P151
[6]  
CALAPAI G, 1991, NEUROSCI RES COMMUN, V9, P53
[7]   OCCURRENCE OF INTERLEUKIN-1 IN CEREBROSPINAL-FLUID OF THE CONSCIOUS CAT [J].
COCEANI, F ;
LEES, J ;
DINARELLO, CA .
BRAIN RESEARCH, 1988, 446 (02) :245-250
[8]   BEHAVIORAL-EFFECTS OF PERIPHERALLY INJECTED INTERLEUKIN-1 - ROLE OF PROSTAGLANDINS [J].
CRESTANI, F ;
SEGUY, F ;
DANTZER, R .
BRAIN RESEARCH, 1991, 542 (02) :330-335
[9]   INTERLEUKIN-1 [J].
DINARELLO, CA .
REVIEWS OF INFECTIOUS DISEASES, 1984, 6 (01) :51-95
[10]  
FONTANA A, 1984, J IMMUNOL, V133, P1696